Review of Protein-Bound Toxins, Possibility for Blood Purification Therapy

Protein-bound uremic retention solutes, i.e. phenolic compounds, such as p-cresylsulfate, and indolic compounds, such as indoxyl sulfate, have been intensively studied in recent years and have been shown to be associated especially with cardiovascular toxicity and adverse outcomes in chronic kidney disease. In this review, we will focus on their toxicity and their removal by dialysis strategies, which is hampered due to their protein binding. Hemodiafiltration slightly improves the removal of protein-bound solutes as compared to hemodialysis, although the clinical benefit on outcomes still needs to be demonstrated. Removal by means of absorption and interference with intestinal generation or renal tubular excretion are interesting alternative strategies under investigation.

[1]  M. Hayashi,et al.  Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. , 2013, International journal of cardiology.

[2]  R. Vanholder,et al.  An update on uremic toxins , 2013, International Urology and Nephrology.

[3]  H. Krum,et al.  Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate. , 2012, International journal of cardiology.

[4]  Masahide Takahashi,et al.  Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. , 2012, American journal of physiology. Cell physiology.

[5]  Matthias Wessling,et al.  A novel approach for blood purification: mixed-matrix membranes combining diffusion and adsorption in one step. , 2012, Acta biomaterialia.

[6]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[7]  R. Vanholder,et al.  Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  T. Meyer,et al.  The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[9]  T. Meyer,et al.  Selectively increasing the clearance of protein-bound uremic solutes. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Shi-Chung Chang,et al.  Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin–Angiotensin–Aldosterone System Associated Epithelial-to-Mesenchymal Transition , 2012, PloS one.

[11]  T. Niwa,et al.  Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production , 2012, Analytical and Bioanalytical Chemistry.

[12]  Seungho Wang,et al.  Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism , 2012, Journal of cellular biochemistry.

[13]  A. Imai,et al.  Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease , 2012, International journal of nephrology.

[14]  Shi-Chung Chang,et al.  Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation , 2012, Kidney international.

[15]  T. Meyer,et al.  Colonic contribution to uremic solutes. , 2011, Journal of the American Society of Nephrology : JASN.

[16]  R. Vanholder,et al.  Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  Luigi Colì,et al.  Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  W. R. Wikoff,et al.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). , 2011, Journal of proteome research.

[19]  N. Levin,et al.  Clearance of p-Cresol Sulfate and &bgr;-2-Microglobulin from Dialysate by Commercially Available Sorbent Technology , 2011, ASAIO journal.

[20]  Z. Massy,et al.  Warning: the unfortunate end of p-cresol as a uraemic toxin. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  A. Teutonico,et al.  Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  T. Meyer,et al.  Contribution of residual function to removal of protein-bound solutes in hemodialysis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[23]  T. Niwa,et al.  Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  Shunsuke Ito,et al.  Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin* , 2010, The Journal of Biological Chemistry.

[25]  R. Vanholder,et al.  Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. , 2010, Artificial organs.

[26]  K. Verbeke,et al.  Uremic toxins originating from colonic microbial metabolism. , 2009, Kidney international. Supplement.

[27]  W. Dehaen,et al.  The uremic retention solute p-cresyl sulfate and markers of endothelial damage. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  E. Mishima,et al.  SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. , 2009, Journal of the American Society of Nephrology : JASN.

[29]  T. Meyer,et al.  Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes? , 2009, Nature Clinical Practice Nephrology.

[30]  Y. Tomino,et al.  Long-Term Effects of the Oral Adsorbent, AST-120, in Patients with Chronic Renal Failure , 2009, The Journal of international medical research.

[31]  Sunny Eloot,et al.  Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  N. Shibahara,et al.  AST-120 Treatment in Pre-Dialysis Period Affects the Prognosis in Patients on Hemodialysis , 2008, Renal failure.

[33]  W. Dehaen,et al.  Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. , 2007, Artificial organs.

[34]  K. Kurokawa,et al.  Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. , 2007, Kidney international.

[35]  D. Savitz,et al.  Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[36]  S. Shaldon Beneficial effect of strict volume control on blood pressure and mortality in patients on hemodialysis , 2007, Nature Clinical Practice Nephrology.

[37]  K. Verbeke,et al.  Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. , 2006, Kidney international.

[38]  Y. Asano,et al.  Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. , 2006, Kidney international.

[39]  V. Faure,et al.  Elevation of circulating endothelial microparticles in patients with chronic renal failure , 2006, Journal of thrombosis and haemostasis : JTH.

[40]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[41]  M. Togawa,et al.  Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  R. Vanholder,et al.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  A. Enomoto,et al.  Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. , 2002, Journal of the American Society of Nephrology : JASN.

[44]  J. Muir,et al.  Resistant starch lowers fecal concentrations of ammonia and phenols in humans. , 1996, The American journal of clinical nutrition.

[45]  C. Wanner,et al.  Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  K. Verbeke,et al.  p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  阿依努爾 阿地江 Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats , 2010 .

[48]  R. Vanholder,et al.  Evolution of protein-bound uraemic solutes during predilution haemofiltration. , 2009, Journal of nephrology.

[49]  T. Meyer,et al.  Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[50]  R. Vanholder,et al.  Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  C. Zoccali,et al.  Plasma met-enkephalin and leu-enkephalin in chronic renal failure. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  M. Ghoneim,et al.  Fine-needle aspiration biopsy: a reproducibility study and a correlation with the tru-cut biopsy in the evaluation of renal allotransplants. , 1987, Nephrology, Dialysis and Transplantation.

[53]  P. Kinnaert,et al.  Parathyroid adenoma causing persistent hypercalcaemia after rhabdomyolysis-induced acute renal failure. , 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.